Cover Image
市場調查報告書

全球學名藥市場預測

Generic Drugs Market Forecast 2016-2021

出版商 Labrinth Analytics LTD 商品編碼 359777
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
全球學名藥市場預測 Generic Drugs Market Forecast 2016-2021
出版日期: 2016年06月14日 內容資訊: 英文
簡介

本報告提供全球學名藥市場相關調查分析,趨勢與收益 (實際成果、預測) 、推動因素、阻礙因素,機會與課題等系統性資訊。

第1章 過去的資料

第2章 全球學名藥市場主要企業

  • Teva Pharmaceutical Industries
  • Novartis
  • Allergan
  • Mylan
  • Pfizer
  • Abbott
  • Aspen
  • Sanofi
  • Fresenius Kabi
  • Sun Pharmaceutical

第3章 主要國家的學名藥市場

  • 北美市場
  • 美國
  • 加拿大
  • 歐洲市場
  • 俄羅斯
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他的歐洲市場
  • 日本
  • 中國
  • 印度
  • 韓國
  • 其他亞洲市場
  • 南美市場
  • 巴西
  • 墨西哥
  • 其他南美市場
  • 其他地區市場

第4章 學名藥市場定性分析

  • 附有效期限的醫藥品
  • 學名藥概要
  • 學名藥的種類
  • 學名藥的分類
  • 美國的法規
  • Hatch-Waxman法案
  • 歐洲的法規
  • 專利補充證明書 (SPC)
  • 歐洲各國的各種法規
  • 日本的法規
  • 中國的法規
  • 學名藥市場概要
  • SWOT分析
  • 波特的五力分析
  • 大環境分析
  • 推動市場要素
  • 阻礙市場要素

第5章 表格的清單

第6章 圖的清單

第7章 企業、其他刊載企業

目錄

The generic drug market will witness significant growth during 2016-2021, driven by primarily product innovation and technological innovations. The global generic drugs market was valued at US$ XXXX m in 2015 and is expected to reach US$ XXXX m, at a CAGR of XXXX % during 2016-2021. The US held the largest share of the global market for generic drugs in 2014 with an estimated XXXX % of the market. As per our analysis the market is experiencing significant growth during the forecast period. Largely due to the Chinese generic drugs market which will observe extensive increase in the healthcare infrastructure. The Chinese market will account for XXXX % of the global market in 2021. The Indian market is also experiencing strong growth on the back of its economic development which is set to increase demand for generics, especially branded generics, which account for XXXX % of the total generic drugs in the country. India is a hub for a number of generic giants operating at a global level.

According to our analysis, the markets in the Asia region is expected to continue their high growth over the forecast period. The emerging markets will also witness an increase in their market shares over the forecast period. We expect these markets to account for a significant share of the market in 2021. We expect the EU5 market to continue to grow over the forecast period. However, the maturation of generic penetration in most of these markets will lead to this region losing market share to other fast growing regions.

image1

image2

image3

image4

image5

Table of Contents

  • Report Summary
  • Introduction to Generic Drugs Market 2015
  • What information can you expect to gain from this report?
  • Market Segmentation
  • Leading National Market for Generic Drugs

1. Historical Data

  • 1.1 Generic Drugs Market 2012
  • 1.2 Generic Drugs Market 2013
  • 1.3 Generic Drugs Market 2014
  • 1.3 Generic Drugs Market 2015

2. Leading Companies in the World Generic Drugs Market

  • 2.1 Teva Pharmaceutical Industries
  • 2.2 Novartis
  • 2.3 Allergan
  • 2.4 Mylan
  • 2.5 Pfizer
  • 2.6 Abbott
  • 2.7 Aspen
  • 2.8 Sanofi
  • 2.9 Fresenius Kabi
  • 2.10 Sun Pharmaceutical

3. Leading National Markets for the Generic Drugs, 2016-2021

  • 3.1 North America Generic Drugs Market: Regional Forecast 2016-2021
  • 3.2 The US Generic Drugs Market Forecast 2016-2021
  • 3.3 The Canada Generic Drugs Market Forecast 2016-2021
  • 3.4 The Europe Generic Drugs Market Forecast 2016-2021
  • 3.5 Russia Generic Drugs Market Forecast 2016-2021
  • 3.6 Germany Generic Drugs Market Forecast 2016-2021
  • 3.7 The France Generic Drugs Market Forecast 2016-2021
  • 3.8 The U.K. Generic Drugs Market Forecast 2016-2021
  • 3.9 The Italy Generic Drugs Market Forecast 2016-2021
  • 3.10 The Spain Generic Drugs Market Forecast 2016-2021
  • 3.11 The rest of Europe Generic Drugs Market Forecast 2016-2021
  • 3.12 The Japan Generic Drugs Market Forecast 2016-2021
  • 3.13 The China Generic Drugs Market Forecast 2016-2021
  • 3.14 The India Generic Drugs Market Forecast 2016-2021
  • 3.15 The South Korea Generic Drugs Market Forecast 2016-2021
  • 3.16 Rest of Asia Generic Drugs Market Forecast 2016-2021
  • 3.17 Latin America Generic Drugs Market Forecast 2016-2021
  • 3.18 The Brazil Generic Drugs Market Forecast 2016-2021
  • 3.19 The Mexico Generic Drugs Market Forecast 2016-2021
  • 3.20 The rest of Latin America Generic Drugs Market Forecast 2016-2021
  • 3.21 The rest of the World Generic Drugs Market Forecast 2016-2021

4. Qualitative Analysis of the Generic Drugs Market, 2016-2021

  • 4.1 Drug with Expiration Date
  • 4.2 Brief Overview of Generic Drugs
  • 4.3 Types of Generic Drugs
  • 4.4 Classification of Generics
  • 4.5 U.S. Regulation
  • 4.6 The Hatch-Waxman Act Title
  • 4.7 Regulation in Europe
  • 4.8 Supplementary Protection Certificates
  • 4.9 Variations of Regulation Among European Countries
  • 4.10 Regulations in Japan
  • 4.11 Regulation in China
  • 4.12 Generic Drugs Market Overview
  • 4.13 SWOT Analysis
  • 4.14 Porter's Analysis
  • 4.15 PESTEL Analysis
  • 4.16 Market Drivers
  • 4.17 Market Restraints

5. List of Tables

  • Table 1 Teva: Historical Sales ($m, AGR%), 2010-2014
  • Table 2 Teva: Revenue Share by Region, 2014
  • Table 3 Teva: Revenue Share by Segment, 2014
  • Table 4 Novartis: Historical Sales ($m, AGR%), 2010-2014
  • Table 5 Novartis: Revenue Share by Region, 2014
  • Table 6 Allergan: Historical Sales ($m, AGR%), 2010-2014
  • Table 7 Allergan: Revenue Share by Region, 2014
  • Table 8 Mylan: Historical Sales ($m, AGR%), 2010-2014
  • Table 9 Pfizer: Historical Sales ($m, AGR%), 2010-2014
  • Table 10 Pfizer: Revenue Share by Region, 2014
  • Table 11 Abbott: Historical Sales ($m, AGR%), 2010-2014
  • Table 12 Abbott: Revenue Share by Segment, 2014
  • Table 13 Aspen: Historical Sales ($m, AGR%), 2010-2014
  • Table 14 Sanofi: Historical Sales ($m, AGR%), 2010-2014
  • Table 15 Sanofi: Revenue Share by Segment, 2014
  • Table 16 Fresenius Kabi: Historical Sales ($m, AGR%), 2010-2014
  • Table 17 Fresenius Kabi: Revenue Share by Region, 2014
  • Table 18 Sun Pharmaceuticals: Historical Sales ($m, AGR%), 2010-2014
  • Table 19 Major Companies with Generic Revenues ($, bn, 2014)
  • Table 20 North America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 21 The U.S. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 22 Canada Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 23 Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 24 Russia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 25 Germany Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 26 France Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 27 U.K. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 28 Italy Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 29 Spain Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 30 Rest of Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 31 Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 32 Japan Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 33 China Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 34 India Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 35 South Korea Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 36 Rest of Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 37 Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 38 Brazil Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 39 Mexico Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 40 Rest of Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 41 Rest of the World Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 42 Market Share Analysis by Country, 2015 (%)
  • Table 43 Drug with Expiration Date
  • Table 44 Porter's Analysis
  • Table 45 PESTEL Analysis

6 Lists of Figures

  • Figure 1 Global Pharmaceutical Market Trend, 2014
  • Figure 2 Global Generic Drugs, 2015 - 2021
  • Figure 3 Global Generic Drugs Market Segmentation Overview, 2015
  • Figure 4 Teva: Historical Sales ($m, AGR%), 2011-2014
  • Figure 5 Baxter International Inc: Historical Sales ($m, AGR %), 2010-2014
  • Figure 6 Teva: Revenue Share by Geography, 2014
  • Figure 7 Teva: Revenue Share by Segment, 2014
  • Figure 8 Novartis: Historical Sales ($m, AGR%), 2010-2014
  • Figure 9 Novartis: Revenue Share by Geography, 2014
  • Figure 10 Allergan: Historical Sales ($m, AGR%), 2010-2014
  • Figure 11 Allergan: Revenue Share by Geography, 2014
  • Figure 12 Mylan: Historical Sales ($m, AGR%), 2010-2014
  • Figure 13 Pfizer: Historical Sales ($m, AGR%), 2010-2014
  • Figure 14 Pfizer: Revenue Share by Geography, 2014
  • Figure 15 Abbott: Historical Sales ($m, AGR%), 2010-2014
  • Figure 16 Abbott: Revenue Share by Segment, 2014
  • Figure 17 Aspen: Historical Sales ($m, AGR%), 2010-2014
  • Figure 18 Sanofi: Historical Sales ($m, AGR%), 2010-2014
  • Figure 19 Sanofi: Revenue Share by Segment, 2014
  • Figure 20 Fresenius Kabi: Historical Sales ($m, AGR%), 2010-2014
  • Figure 21 Fresenius Kabi: Revenue Share by Geography, 2014
  • Figure 22 Sun Pharmaceuticals: Historical Sales ($m, AGR%), 2011-2014
  • Figure 23 North America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 24 The U.S. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 25 Canada Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 26 Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 27 Russia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 28 Germany Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 29 France Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 30 U.K. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 31 Italy Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 32 Spain Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 33 Rest of Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 34 Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 35 Japan Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 36 China Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 37 India Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 38 South Korea Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 39 Rest of Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 40 Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 41 Brazil Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 42 Mexico Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 43 Rest of Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 44 Rest of the World Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 45 Market Share Analysis by, Country (%)

7 Companies and Other Organizations Mentioned

  • Abbott
  • AbbVie
  • Actavis
  • Alcon (Novartis)
  • Allergan (Actavis)
  • Amgen
  • Anda Inc
  • APP Pharmaceuticals
  • Arrow Group (Actavis)
  • Ascent Pharmahealth (Actavis)
  • ASKA Pharmaceuticals
  • Aspen
  • Bergamo (Amgen)
  • Bioniche Pharma (Mylan)
  • BMP Sunstone (Sanofi)
  • CFR Pharmaceuticals (Abbott)
  • Cipla
  • Dabur Pharma (Fresenius Kabi)
  • Daiichi Sankyo
  • Dalim BioTech
  • Dr Reddy's Laboratory
  • Ebewe Pharma (Novartis)
  • Eden Biopharm Group
  • Egis
  • Elder Pharmaceuticals (Torrent Pharmaceuticals)
  • Eli Lilly
  • Elyson Pharmaceuticals
  • Laboratorio Sanderson (Fresenius Kabi)
  • Laboratorios Best
  • Laboratorios Kendrick (Sanofi)
  • Lek (Novartis)
  • Lupin
  • Mayne Pharma (Hospira)
  • Medley (Sanofi)
  • Merck KGaA
  • MN Pharma (Amgen)
  • Momenta Pharmaceuticals
  • Mylan
  • Natco Pharma
  • Nexus Pharmaceuticals
  • Teva
  • The Laboratory Of Analytical Services International Ltd
  • Towa
  • UDL Laboratories
  • Uteron Pharma (Actavis)
  • Valeant Pharmaceuticals
  • Wal-Mart
  • Warner Chilcott (Actavis)
  • Wockhardt
  • Wyeth (Pfizer)
  • Zentiva (Sanofi)
  • Zhejiang Chiral Medicine Chemicals Co. Ltd
  • EMA (European Medicines Agency)
  • FDA (US Food and Drug Administration)
  • GlaxoSmithKline (GSK)
  • Merck & Co.
  • MHLW (Ministry of Health, Labour, and Welfare)
  • MHRA (Medicines and Healthcare Products Regulatory Agency)
  • NICE (the National Institute for Health and Care Excellence)
  • WHO (World Health Organization)
Back to Top